- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2 Negative Breast Cancer in Australia
Total 421 results
-
Olema Pharmaceuticals, Inc.PfizerRecruiting
-
Arbeitsgemeinschaft medikamentoese TumortherapieGlaxoSmithKlineTerminatedMetastatic Breast CancerAustria
-
Trans Tasman Radiation Oncology GroupActive, not recruitingBreast CancerAustralia, New Zealand
-
Medical University of ViennaUnknownMetastatic Breast CancerAustria
-
Eli Lilly and CompanyCompletedMetastatic Breast CancerSpain, Australia, Belgium, Turkey, Russian Federation
-
BeiGeneRecruitingBreast Cancer | Small Cell Lung Cancer | Gastric Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid Tumor | Endometrial Cancer | Hormone Receptor Positive HER-2 Negative Breast Cancer | Hormone-receptor-positive Breast CancerUnited States, Australia
-
Hoffmann-La RocheCompleted
-
Uppsala UniversityRoyal Marsden NHS Foundation Trust; Uppsala University Hospital; Westmead Breast... and other collaboratorsRecruitingBreast Cancer | Breast Carcinoma in Situ | Breast Cancer Invasive | Breast AsymmetryUnited Kingdom, Sweden, Australia
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
DualityBio Inc.BioNTech SERecruitingMetastatic Breast CancerUnited States, China, Australia
-
Eli Lilly and CompanyTerminatedBreast CancerMexico, France, Australia, Argentina, South Africa
-
Novartis PharmaceuticalsActive, not recruitingTriple Negative Breast NeoplasmsFrance, Italy, Croatia, Taiwan, Australia, Argentina, Korea, Republic of, China, Israel, Russian Federation, Slovakia, Slovenia, United Kingdom, Germany, Mexico, Switzerland, Spain, Brazil, Hungary, Malaysia, South Africa, Austria, ... and more
-
Trans Tasman Radiation Oncology GroupPeter MacCallum Cancer Centre, AustraliaCompleted
-
St Vincent's Hospital, SydneyNovartisRecruitingBreast CancerAustralia
-
ETOP IBCSG Partners FoundationCompleted
-
St George Hospital, AustraliaAstraZenecaUnknown
-
Western Sydney Local Health DistrictSt George Hospital, AustraliaCompletedBreast Cancer | CYP2D6 PolymorphismAustralia
-
Havah Therapeutics Pty LtdAstraZenecaUnknownBreast Cancer | Arthralgia | OsteoporosisAustralia
-
Hoffmann-La RocheTerminated
-
Hoffmann-La RocheCompletedBreast Cancer, Colorectal Cancer, Gastric CancerAustria
-
Central European Cooperative Oncology GroupTerminatedMetastatic Breast CancerHungary, Austria
-
Neovii BiotechTerminatedAdvanced Breast Cancer | Metastatic Breast CancerSpain, Austria, France, Germany, Italy
-
Barwon HealthUnknown
-
Trans Tasman Radiation Oncology Group3MCompleted
-
Multitude Therapeutics Inc.Tigermed Consulting Co., LtdRecruitingOvarian Cancer | Ovarian Epithelial Cancer | Lung Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Advanced Cancer | Ovarian Clear Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial... and other conditionsChina, Australia
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
MacroGenicsCompletedHER-2 Positive Breast Cancer | Metastatic NeoplasmUnited States, Spain, Italy, Canada, Israel, Belgium, Germany, Czechia, Austria, Korea, Republic of, Denmark, United Kingdom, Portugal, France, Poland, Netherlands, Finland, Puerto Rico
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, South Africa, New Zealand
-
ETOP IBCSG Partners FoundationCompleted
-
PureTechNovotech (Australia) Pty LimitedTerminatedLymphoedema | Breast Cancer Related LymphoedemaUnited States, Australia
-
IpsenTerminated
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSwitzerland, Australia, Slovenia, Italy, Sweden, Hungary, Israel, South Africa, New Zealand
-
ExelixisRecruitingCervical Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Epithelial Ovarian Cancer | Metastatic Castration-resistant Prostate Cancer | Hormone Receptor-positive Breast Cancer | SCCHN | Esophageal SCC | Tissue Factor-Expressing Solid TumorsUnited States, Spain, Australia, Belgium, France, Italy, Netherlands, United Kingdom, Korea, Republic of
-
Medical University of GrazActive, not recruiting
-
Medical University of ViennaUniversity of Natural Resources and Life Sciences, Vienna, AustriaCompleted
-
Hoffmann-La RocheCompleted
-
Regeneron PharmaceuticalsSuspendedNon-Small Cell Lung Cancer | Triple Negative Breast Cancer | Merkel Cell Carcinoma | Basal Cell Carcinoma | Oropharynx Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States, Australia
-
PfizerCompletedBreast CancerAustralia, India
-
Siemens Healthcare QTMedical University of ViennaCompletedBreast Cancer DiagnosisAustria
-
Johannes Kepler University of LinzCharles University, Czech Republic; Charite University, Berlin, Germany; German... and other collaboratorsRecruiting
-
Arbeitsgemeinschaft medikamentoese TumortherapieRoche Pharma AGCompleted
-
Hoffmann-La RocheCompleted
-
Monash UniversityRoyal Perth HospitalRecruitingBreast Cancer | Mastectomy | Breast Cancer Female | Breast Conserving SurgeryAustralia, New Zealand, Hong Kong
-
Medical University of GrazWithdrawnBreast Cancer | Radiotherapy Side EffectAustria
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
German Breast GroupRecruiting